These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28141867)

  • 41. Efficacy of a lay health worker led group antiretroviral medication adherence training among non-adherent HIV-positive patients in KwaZulu-Natal, South Africa: results from a randomized trial.
    Peltzer K; Ramlagan S; Jones D; Weiss SM; Fomundam H; Chanetsa L
    SAHARA J; 2012 Nov; 9(4):218-26. PubMed ID: 23234350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia.
    Chow JY; Alsan M; Armstrong W; del Rio C; Marconi VC
    AIDS Care; 2015; 27(7):844-8. PubMed ID: 25660100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: A cross-sectional study.
    Buh A; Deonandan R; Gomes J; Krentel A; Oladimeji O; Yaya S
    PLoS One; 2023; 18(4):e0283991. PubMed ID: 37014900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intestinal parasitic infections in relation to CD4(+) T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon.
    Nsagha DS; Njunda AL; Assob NJC; Ayima CW; Tanue EA; Kibu OD; Kwenti TE
    BMC Infect Dis; 2016 Jan; 16():9. PubMed ID: 26754404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
    Silveira MP; Maurer P; Guttier MC; Moreira LB
    J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon.
    Meresse M; March L; Kouanfack C; Bonono RC; Boyer S; Laborde-Balen G; Aghokeng A; Suzan-Monti M; Delaporte E; Spire B; Carrieri MP; Laurent C;
    HIV Med; 2014 Sep; 15(8):478-87. PubMed ID: 24589279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal antiretroviral therapy adherence as evaluated by CASE index score tool is associated with virological suppression in HIV-infected adults in Dakar, Senegal.
    Byabene AK; Fortes-Déguénonvo L; Niang K; Manga MN; Bulabula ANH; Nachega JB; Seydi M
    Trop Med Int Health; 2017 Jun; 22(6):776-782. PubMed ID: 28407436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in Vietnam.
    Tran BX; Hwang J; Nguyen LH; Nguyen AT; Latkin NR; Tran NK; Minh Thuc VT; Nguyen HL; Phan HT; Le HT; Tran TD; Latkin CA
    PLoS One; 2016; 11(12):e0168687. PubMed ID: 28005937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.
    Pasternak AO; de Bruin M; Bakker M; Berkhout B; Prins JM
    PLoS One; 2015; 10(10):e0140791. PubMed ID: 26468956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: a cross-sectional study in Salvador, Brazil.
    Betancur MN; Lins L; Oliveira IR; Brites C
    Braz J Infect Dis; 2017; 21(5):507-514. PubMed ID: 28535397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adherence to antiretroviral treatment and quality of life among transgender women living with HIV/AIDS in São Paulo, Brazil.
    Sabino TE; Avelino-Silva VI; Cavalcantte C; Goulart SP; Luiz OC; Fonseca LAM; Casseb JS
    AIDS Care; 2021 Jan; 33(1):31-38. PubMed ID: 31906696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group.
    Yildiz Sevgi D; Gunduz A; Altuntas Aydin O; Mete B; Sargin F; Kumbasar Karaosmanoglu H; Uzun N; Yemisen M; Dokmetas I; Tabak F
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1192-1198. PubMed ID: 28854809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia.
    Chkhartishvili N; Rukhadze N; Svanidze M; Sharvadze L; Dehovitz JA; Tsertsvadze T; McNutt LA; del Rio C
    J Int AIDS Soc; 2014; 17(1):18885. PubMed ID: 24721464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
    Mulu A; Maier M; Liebert UG
    PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
    Orrell C; Cohen K; Leisegang R; Bangsberg DR; Wood R; Maartens G
    AIDS Res Ther; 2017 Apr; 14(1):20. PubMed ID: 28376815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A decade of antiretroviral therapy: a profile of patients with 10 years of highly effective triple therapy].
    Wilson G; Wolff M
    Rev Chilena Infectol; 2012 Jun; 29(3):337-43. PubMed ID: 23096476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.